APP and Alzheimer disease: These results suggest that ginsenoside Ro is effective in reducing Aβ deposition and ameliorating neuronal apoptosis in the cerebral cortex and hippocampus of APP/PS1 mice, thus potentially attenuating the pathologic effects associated with AD.